Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
VSTM2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
COL5A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HILPDA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RRP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBC1D10A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPB41L4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MBNL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPPA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNRG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LZTS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOLR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FKRP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HRASLS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARNTL2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HS1BP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on